274 related articles for article (PubMed ID: 18375488)
1. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure.
Mueller T; Dieplinger B; Gegenhuber A; Poelz W; Pacher R; Haltmayer M
Clin Chem; 2008 Apr; 54(4):752-6. PubMed ID: 18375488
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.
Manzano-Fernández S; Mueller T; Pascual-Figal D; Truong QA; Januzzi JL
Am J Cardiol; 2011 Jan; 107(2):259-67. PubMed ID: 21211603
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.
Zhang R; Zhang Y; Zhang J; An T; Huang Y; Guo X; Januzzi JL; Cappola TP; Yin S; Wang Y; Zhou Q; Zou C; Ji S; Lv R
PLoS One; 2014; 9(10):e110976. PubMed ID: 25347817
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
[TBL] [Abstract][Full Text] [Related]
6. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) study.
Dieplinger B; Egger M; Koehler W; Firlinger F; Poelz W; Lenz K; Haltmayer M; Mueller T
Clin Chim Acta; 2012 Mar; 413(5-6):587-93. PubMed ID: 22155704
[TBL] [Abstract][Full Text] [Related]
8. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study.
Januzzi JL; Peacock WF; Maisel AS; Chae CU; Jesse RL; Baggish AL; O'Donoghue M; Sakhuja R; Chen AA; van Kimmenade RR; Lewandrowski KB; Lloyd-Jones DM; Wu AH
J Am Coll Cardiol; 2007 Aug; 50(7):607-13. PubMed ID: 17692745
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea.
Shah RV; Chen-Tournoux AA; Picard MH; van Kimmenade RR; Januzzi JL
Circ Heart Fail; 2009 Jul; 2(4):311-9. PubMed ID: 19808354
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department.
Dieplinger B; Gegenhuber A; Kaar G; Poelz W; Haltmayer M; Mueller T
Clin Biochem; 2010 Jun; 43(9):714-9. PubMed ID: 20153308
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
[TBL] [Abstract][Full Text] [Related]
12. Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency.
Kim MS; Jeong TD; Han SB; Min WK; Kim JJ
J Korean Med Sci; 2015 May; 30(5):569-75. PubMed ID: 25931787
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
[TBL] [Abstract][Full Text] [Related]
15. Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure.
Bayes-Genis A; Pascual-Figal D; Januzzi JL; Maisel A; Casas T; Valdés Chávarri M; Ordóñez-Llanos J
Rev Esp Cardiol; 2010 Oct; 63(10):1171-8. PubMed ID: 20875357
[TBL] [Abstract][Full Text] [Related]
16. Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure.
Manzano-Fernández S; Januzzi JL; Pastor-Pérez FJ; Bonaque-González JC; Boronat-Garcia M; Pascual-Figal DA; Montalban-Larrea S; Navarro-Peñalver M; Andreu-Cayuelas JM; Valdés M
Cardiology; 2012; 122(3):158-66. PubMed ID: 22832599
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Long-Term Mortality in Patients With Acute Heart Failure.
Jin M; Wei S; Gao R; Wang K; Xu X; Yao W; Zhang H; Zhou Y; Xu D; Zhou F; Li X
Int Heart J; 2017 May; 58(3):409-415. PubMed ID: 28496020
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial.
Anand IS; Rector TS; Kuskowski M; Snider J; Cohn JN
Circ Heart Fail; 2014 May; 7(3):418-26. PubMed ID: 24622243
[TBL] [Abstract][Full Text] [Related]
19. Analysis of BAG3 plasma concentrations in patients with acutely decompensated heart failure.
Gandhi PU; Gaggin HK; Belcher AM; Harisiades JE; Basile A; Falco A; Rosati A; Piscione F; Januzzi JL; Turco MC
Clin Chim Acta; 2015 May; 445():73-8. PubMed ID: 25753466
[TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction.
Shah KB; Kop WJ; Christenson RH; Diercks DB; Henderson S; Hanson K; Li SY; deFilippi CR
Clin Chem; 2011 Jun; 57(6):874-82. PubMed ID: 21515743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
